|
⚲
|
| Keyboard |
| Pryor Cashman LLP
✚
|
|
|---|---|
| CIK # | 0001557007 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001557007] | |
| 4 | [0001557007] | |
| SC 13G | [0001557007] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Pryor Cashman LLP | Marina Biotech Inc | [2012-08-31] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pryor Cashman LLP | |
| Adhera Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adhera Therapeutics Inc MRNA
common stock, par value $0.006 per share
|
2014-02-10 | Sell | 15,000 | $1.02 | 15,300 |
|
Adhera Therapeutics Inc MRNA
common stock, par value $0.006 per share
|
2014-02-07 | Sell | 59,000 | $1.01 | 59,590 |
|
Adhera Therapeutics Inc MRNA
common stock, par value $0.006 per share
|
2014-02-06 | Sell | 34,041 | $0.95 | 32,339 |
|
Adhera Therapeutics Inc MRNA
common stock, par value $0.006 per share
|
2013-10-04 | Sell | 35,000 | $0.24 | 8,400 |
|
Adhera Therapeutics Inc MRNA
common stock, par value $0.006 per share
|
2013-10-03 | Sell | 65,000 | $0.25 | 16,250 |